The third sibling, RUNX3, can form a ternary complex with β‐catenin and TCF7L2, and attenuates their DNA‐binding affinity ultimately acting as a tumor suppressor in CRC (Ito et al., 2008). The gene discussed is TCF7L2; the disease is colorectal carcinoma.